J&J tops 4Q earnings forecasts as profit, revenue slip

J&J CFO on Earnings Forecast, Costs and Consumer Spinoff

Johnson & Johnson CFO Joseph Wolk discusses the company's stronger-than-expected earnings forecast for 2023 and cost pressures with Guy Johnson and Alix Steel on "Bloomberg Markets." (Source: Bloomberg)

J&J Tops 4th-Quarter Earnings Forecasts as Profit, Revenue Slip

Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue. The health care giant also debuted on Tuesday a better-than-expected 2023 earnings forecast. J&J said fourth-quarter earnings slipped 26 percent to $3.52 billion and revenue declined 4.4 percent to $23.71 billion. Company sales were hurt last year by the strong U.S. dollar, which is currently worth mo…

J&J tops 4Q earnings forecasts as profit, revenue slip

By TOM MURPHY Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue. The health care giant also debuted on Tuesday a better-than-expected 2023 earnings forecast. J&J said fourth-quarter earnings slipped 26% to $3.52 billion and revenue declined 4.4% to $23.71 billion. Company sales were hurt last year by the strong U.S. dollar, which is currently worth mo…

J&J tops 4Q earnings forecasts as profit, revenue slip

Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue.The health care giant also debuted on Tuesday a better-than-expected 2023 earnings forecast.J&J; said fourth-quarter earnings slipped 26% to $3.52 billion and revenue declined 4.4% to $23.71 billion. Company sales were hurt last year by the strong U.S. dollar, which is currently worth more than a euro.…

J&J tops 4Q earnings forecasts as profit, revenue slip

Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue.The health care giant also debuted on Tuesday a better-than-expected 2023 earnings forecast.J&J; said fourth-quarter earnings slipped 26% to $3.52 billion and revenue declined 4.4% to $23.71 billion. Company sales were hurt last year by the strong U.S. dollar, which is currently worth more than a euro.…

J&J tops 4Q earnings forecasts as profit, revenue slip

Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and sinking COVID-19 vaccine sales hurt revenue. The health care giant also debuted on Tuesday a better-than-expected 2023 earnings forecast.